Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Clinical Pathology 2002;55:879; doi:10.1136/jcp.55.11.879
Copyright © 2002 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.
Journal of Clinical Pathology 2002;55:879
© 2002 Journal of Clinical Pathology

CORRESPONDENCE

Androgen receptor expression in ductal carcinoma in situ of the breast: relation to oestrogen and progesterone receptors

M Kasami1 and D L Page2

1 Shizuoka Cancer Center Hospital, Naga-Izumi, 411–8777, Japan
2 Department of Pathology, Rm-C-3309, MCN, Vanderbilt University Medical Center, 1161 21st Av. So., Nashville, TN 37232–2561, USA; david.page@mcmail.vanderbilt.edu

Keywords: ductal carcinoma in situ; breast tumours; androgen receptors; CAG repeats

The first 150 words of the full text of this article appear below.

We wish to add a reference to the list included in the paper of Selim and colleagues1 concerning androgen receptors in ductal carcinoma in situ (DCIS) of the breast that appeared in the Journal of Clinical Pathology in the first issue of 2002. Although the authors state1 that androgen receptors in DCIS have not been reported previously, we had studied this and published a paper2 dealing with our observations, in addition to CAG repeat lengths in the androgen receptor in DCIS.

  1. Selim AG, El-Ayat G, Wells CA. Androgen receptor expression in ductal carcinoma in situ of the breast: relation to oestrogen and progesterone receptors. J Clin Pathol 2002;55:14–16.[Abstract/Free Full Text]
  2. Kasami M, Gobbi H, Dupont WD, et al. Androgen receptor CAG repeat lengths in ductal carcinoma in situ of breast, longest in the apocrine variety. The Breast 2000;9:23–7.

 

Authors’ reply

A A Selim3, G El-Ayat3 and C A Wells3

3 Department of Histopathology, St Bartholomew's Hospital, St Bartholomew's and the Royal School of Medicine and Dentistry, Queen Mary and Westfield College, University of London, West Smithfield, London EC1A 7BE, UK;
aaselim@doctors.net.uk

Thank you for this information and the opportunity to reply. Unfortunately, the study of androgen receptor (AR) CAG repeats by Kasami and colleagues1 is not included in the usual searches and this appears to be the reason for overlooking this reference. In this study, cases of fibroadenoma, ductal carcinoma in situ (DCIS), and invasive mammary carcinoma were included. Twenty four cases of DCIS were tested for AR CAG repeats . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs